2012 54th ASH Annual Meeting - účast ČR

101. Red Cells and Erythropoiesis, Structure and Function, Metabolism and Survival, Excluding Iron: Poster II

102. Regulation of Iron Metabolism: Poster I

201. Granulocytes, Monocytes and Macrophages: Myeloid Cell Development and Function

311. Disorders of Platelet Number or Function: Poster III

603. Oncogenes and Tumor Suppressors III

603. Oncogenes and Tumor Suppressors: Poster I

604. Molecular Pharmacology, Drug Resistance

611. Leukemias - Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis

612. Acute Lymphoblastic Leukemia - Pathophysiology & Clinical Studies

613. Acute Myeloid Leukemia - Pathophysiology & Clinical Studies

615. Acute Myeloid Leukemia - Therapy, excluding Transplantation

622. Non-Hodgkin Lymphoma - Biology, excluding Therapy

623. Lymphoma - Chemotherapy, excluding Pre-Clinical Models

624. Lymphoma - Therapy with Biologic Agents, excluding Pre-Clinical Models

625. Lymphoma - Pre-Clinical - Chemotherapy and Biologic Agents

631. Chronic Myeloid Leukemia - Biology and Pathophysiology, excluding Therapy

632. Chronic Myeloid Leukemia - Therapy

633. Myelodysplastic Syndromes

635. Myeloproliferative Syndromes - Basic Science

641. CLL - Biology and Pathophysiology, excluding Therapy

642. CLL - Therapy, excluding Transplantation

651. Myeloma - Biology and Pathophysiology, excluding Therapy

653. Myeloma - Therapy, excluding Transplantation

721. Clinical Allogeneic Transplantation - Conditioning Regimens, Engraftment and Acute Transplant Toxicities

723. Clinical Allogeneic and Autologous Transplantation - Late Complications and Approaches to Disease Recurrence

731. Clinical Allogeneic and Autologous Transplantation - Results: Autologous or Allogeneic Transplantation

901. Health Services and Outcomes Research